Goldman Sachs Group Inc Atri Cure, Inc. Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 422,498 shares of ATRC stock, worth $13 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
422,498
Previous 583,779
27.63%
Holding current value
$13 Million
Previous $13.3 Million
10.88%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ATRC
# of Institutions
212Shares Held
49.7MCall Options Held
12KPut Options Held
7.2K-
Vanguard Group Inc Valley Forge, PA4.66MShares$143 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$142 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.97MShares$122 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.83MShares$87 Million1.47% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.79MShares$85.7 Million0.5% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.43B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...